SECsense Logo

Entera Bio Ltd. 8-K Report: Key Insights on Warrants & Ordinary Shares

$ENTX
Form 8-K
Filed on: 2025-01-10
Source
Entera Bio Ltd. 8-K Report: Key Insights on Warrants & Ordinary Shares

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Identification:
  • The company is Entera Bio Ltd. with a CIK (Central Index Key) of 0001638097.
  1. Filing Type:
  • This document is identified as an 8-K, which is typically used for reporting major events that shareholders should know about.
  1. Reporting Date:
  • The report covers a specific date: January 10, 2025.
  1. Class of Stock:
  • The report includes information about Ordinary Shares with a par value of NIS 0.0000769.
  1. Warrants Information:
  • The financial report details warrants issued by the company:
    • Each warrant is exercisable for half of an Ordinary Share.
    • The exercise price for these warrants is $5.85 per Ordinary Share.
  1. Stock Exchange Listing:
  • The company's stock is listed on the NASDAQ under the ticker symbol ENTX.
  1. Location:
  • The company is headquartered in Kiryat Hadassah, Jerusalem, Israel.
  1. Document Structure:
  • The document employs XBRL (eXtensible Business Reporting Language) for structured financial reporting, which is compliant with SEC filing requirements.

Overall, this financial report section primarily focuses on the issuance of warrants that can impact the ordinary shares of Entera Bio Ltd. and provides essential details regarding the company's share structure and compliance with SEC regulations.